Page last updated: 2024-10-30

mazindol and Cocaine Abuse

mazindol has been researched along with Cocaine Abuse in 3 studies

Mazindol: Tricyclic anorexigenic agent unrelated to and less toxic than AMPHETAMINE, but with some similar side effects. It inhibits uptake of catecholamines and blocks the binding of cocaine to the dopamine uptake transporter.

Research Excerpts

ExcerptRelevanceReference
"Potential medications for cocaine abusers include: anticocaine catalytic antibodies, which could serve as circulating peripheral blockers of cocaine that prevents its action in the brain; and 3-phenyltropane cocaine analogs, which could serve as potent, selective, and long-lasting substitutes that reduce drug-seeking."3.71Anticocaine catalytic antibodies have no affinity for RTI compounds: implications for treatment. ( Bharat, N; Carroll, FI; Kuhar, MJ; Landry, DW, 2001)
"Mazindol, therefore, is an attractive scaffold for both understanding the molecular determinants of serotonin/dopamine transporter selectivity and for the development of novel drug abuse treatments."1.40Binding of mazindol and analogs to the human serotonin and dopamine transporters. ( Jensen, HH; Koldsø, H; Møller, PT; Schiøtt, B; Schjøth-Eskesen, C; Severinsen, K; Sinning, S; Thorup, KA; Wiborg, O, 2014)

Research

Studies (3)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's2 (66.67)29.6817
2010's1 (33.33)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Severinsen, K1
Koldsø, H1
Thorup, KA1
Schjøth-Eskesen, C1
Møller, PT1
Wiborg, O1
Jensen, HH1
Sinning, S1
Schiøtt, B1
Ukairo, OT1
Ramanujapuram, S1
Surratt, CK1
Kuhar, MJ1
Carroll, FI1
Bharat, N1
Landry, DW1

Other Studies

3 other studies available for mazindol and Cocaine Abuse

ArticleYear
Binding of mazindol and analogs to the human serotonin and dopamine transporters.
    Molecular pharmacology, 2014, Volume: 85, Issue:2

    Topics: Binding Sites; Cells, Cultured; Cocaine-Related Disorders; Dopamine Plasma Membrane Transport Protei

2014
Fluctuation of the dopamine uptake inhibition potency of cocaine, but not amphetamine, at mammalian cells expressing the dopamine transporter.
    Brain research, 2007, Feb-02, Volume: 1131, Issue:1

    Topics: Amphetamine; Amphetamine-Related Disorders; Animals; Benztropine; Binding, Competitive; Brain; Brain

2007
Anticocaine catalytic antibodies have no affinity for RTI compounds: implications for treatment.
    Synapse (New York, N.Y.), 2001, Volume: 41, Issue:2

    Topics: Adrenergic Uptake Inhibitors; Antibodies, Catalytic; Antibody Affinity; Brain; Carrier Proteins; Coc

2001